Penobscot Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,670
Closed -$239K 197
2018
Q3
$239K Hold
2,670
0.05% 188
2018
Q2
$212K Sell
2,670
-790
-23% -$65.6K 0.05% 193
2018
Q1
$309K Buy
3,460
+450
+15% +$43.2K 0.07% 170
2017
Q4
$314K Sell
3,010
-400
-12% -$45.1K 0.09% 157
2017
Q3
$497K Buy
3,410
+200
+6% +$27.2K 0.15% 124
2017
Q2
$417K Buy
3,210
+260
+9% +$31.9K 0.13% 135
2017
Q1
$367K Hold
2,950
0.12% 137
2016
Q4
$341K Hold
2,950
0.12% 137
2016
Q3
$308K Hold
2,950
0.11% 146
2016
Q2
$291K Sell
2,950
-200
-6% -$20.7K 0.1% 146
2016
Q1
$315K Hold
3,150
0.12% 139
2015
Q4
$377K Hold
3,150
0.12% 144
2015
Q3
$341K Hold
3,150
0.11% 147
2015
Q2
$365K Buy
3,150
+70
+2% +$8K 0.11% 155
2015
Q1
$355K Buy
3,080
+280
+10% +$33.5K 0.11% 149
2014
Q4
$313K Hold
2,800
0.1% 150
2014
Q3
$265K Buy
+2,800
New +$253K 0.09% 155
2014
Q1
Sell
-4,000
Closed -$338K 174
2013
Q4
$338K Buy
+4,000
New +$317K 0.12% 131

Other funds holding CELG

Penobscot Investment Management's CELG Position: Q4 2018 in Review

Penobscot Investment Management sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 2,670 shares — an estimated $239K sold.

Penobscot Investment Management first reported a position in CELG in Q4 2013 and held it in 18 quarters. The position peaked at $497K in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Penobscot Investment Management reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Penobscot Investment Management sold 2,670 Celgene Corp shares in Q4 2018, an estimated $239K.
  • Penobscot Investment Management first reported a position in Celgene Corp in Q4 2013 and held it in 18 quarters.
  • Penobscot Investment Management's Celgene Corp position peaked at $497K in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Penobscot Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.